Evidence map›Paper›PMID 36190410›Full record

ArticleMicrobiology spectrum2022

Parasitemia Levels in Trypanosoma cruzi Infection in Spain, an Area Where the Disease Is Not Endemic: Trends by Different Molecular Approaches.

Maria D Flores-Chavez, Alba Abras, Cristina Ballart, Ismael Ibáñez-Perez, Pilar Perez-Gordillo, Montserrat Gállego, Carmen Muñoz, Zaira Moure, Elena Sulleiro, Javier Nieto and 4 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Long-Term Parasitological Clearance and Cardiac Progression inTropical medicine and infectious disease · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Maria D Flores-Chavez *National Centre for Microbiology, Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain.ORCID 0000-0003-2597-3100
Alba Abras *Departament de Biologia, Universitat de Girona, Girona, Spain.ORCID 0000-0003-2002-1186
Cristina BallartSecció de Parasitologia, Departament de Biologia, Sanitat i Medi Ambient, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, Spain.
Ismael Ibáñez-PerezNational Centre for Microbiology, Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain.
Pilar Perez-GordilloNational Centre for Microbiology, Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain.
Montserrat GállegoSecció de Parasitologia, Departament de Biologia, Sanitat i Medi Ambient, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, Spain.
Carmen MuñozServei de Microbiologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Zaira MoureServicio de Microbiología, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Elena SulleiroCentro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain.
Javier NietoNational Centre for Microbiology, Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain.
Emilia García DiezNational Centre for Microbiology, Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain.
Lorena SimónNational Centre of Epidemiology, Instituto de Salud Carlos IIIgrid.413448.e, Madrid, Spain.
Israel CruzCentro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III (CIBERINFEC, ISCIII), Madrid, Spain.
Albert PicadoFoundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
Instituto de Salud Carlos III · ESFIND · CHUniversitat Autònoma de Barcelona · ESMarqués de Valdecilla University Hospital · ESUniversitat de Barcelona · ESUniversitat de Girona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trypanosoma cruzi infection has expanded globally through human migration. In Spain, the mother-to-child route is the mode of transmission contributing to autochthonous Chagas disease (CD); however, most people acquired the infection in their country of origin and were diagnosed in the chronic phase (imported chronic CD). In this context, we assessed the quantitative potential of the Loopamp Trypanosoma cruzi detection kit (Sat-TcLAMP) based on satellite DNA (Sat-DNA) to determine parasitemia levels compared to those detected by real-time quantitative PCRs (qPCRs) targeting Sat-DNA (Sat-qPCR) and kinetoplast DNA minicircles (kDNA-qPCR). This study included 173 specimens from 39 autochthonous congenital and 116 imported chronic CD cases diagnosed in Spain. kDNA-qPCR showed higher sensitivity than Sat-qPCR and Sat-TcLAMP. According to all quantitative approaches, parasitemia levels were significantly higher in congenital infection than in chronic CD (1 × 10

Indexed as

Chagas DiseaseTrypanosoma cruziDNA, KinetoplastDNA, ProtozoanDNA, SatelliteFemaleHumansInfectious Disease Transmission, VerticalParasitemiaReal-Time Polymerase Chain ReactionSpainDNA, KinetoplastDNA, ProtozoanDNA, Satelliteacute reactivationChagas diseasechronic infectioncongenital infectionLAMPmolecular diagnosisparasite loadparasitemia quantificationqPCRTrypanosoma cruzi

Identifiers

PMID36190410
PMCPMC9603785
OpenAlexW4300690637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.